Roberts M Scot

CIK 00017059051 companyGAITHERSBURG, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001705905

Recent Transactions

50 trades

Award
Altimmune, Inc.$ALT
Restricted Stock Units
2026-02-26+95,430→ 95,430 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2026-02-26+222,670→ 222,670 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2026-02-02−7,775→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2026-02-02+7,775→ 115,153 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2026-02-02$5.55/sh−2,329→ 112,824 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2026-01-31$3.07/sh+5,567→ 107,378 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2026-01-30+9,275→ 104,670 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2026-01-30−9,275→ 9,275 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2026-01-30$5.60/sh−2,859→ 101,811 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2026-01-27$6.18/sh−4,748→ 95,395 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2026-01-27−15,850→ 47,550 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2026-01-27+15,850→ 100,143 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2026-01-25$5.50/sh−4,373→ 84,293 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2026-01-25−14,600→ 29,200 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2026-01-25+14,600→ 88,666 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-07-31$3.14/sh+846→ 74,066 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-02-02+7,775→ 75,536 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-02-02$6.64/sh−2,316→ 73,220 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-02-02+7,775→ 7,775 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-02-01+6,166→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-02-01+6,166→ 69,562 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-02-01$6.64/sh−1,801→ 67,761 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-31$5.18/sh+3,184→ 63,396 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-01-30+9,275→ 18,550 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-30$7.00/sh−2,709→ 60,212 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-30+9,275→ 62,921 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2025-01-27+183,600→ 183,600 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2025-01-27+63,400→ 63,400 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-01-25+14,600→ 43,800 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-25+14,600→ 57,910 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-25$6.98/sh−4,264→ 53,646 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-07-31$5.41/sh+650→ 43,310 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-02-02$9.32/sh−2,330→ 42,660 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-02-02+7,775→ 44,990 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2024-02-02−7,775→ 15,550 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2024-02-01−6,166→ 6,166 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-02-01$9.88/sh−1,801→ 37,215 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-02-01+6,166→ 39,016 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-01-31$2.69/sh+5,860→ 32,850 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-01-30+9,275→ 29,699 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-01-30$9.80/sh−2,709→ 26,990 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2024-01-30−9,275→ 27,825 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2024-01-25+58,400→ 58,400 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2024-01-25+163,200→ 163,200 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-07-31$2.81/sh+568→ 20,424 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2023-02-02−7,775→ 23,325 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-02-02$15.04/sh−2,375→ 19,856 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-02-02+7,775→ 22,231 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2023-02-01−6,166→ 12,332 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-02-01+6,166→ 16,639 total

Companies

Altimmune, Inc.
Chief Scientific Officer
$ALT

Recent Filings

Address

910 CLOPPER ROAD SUITE 201S

GAITHERSBURG, MD, 20878

View on SEC.gov